Meprin and ADAM proteases as triggers of systemic inflammation in sepsis
Open Access
- 11 November 2021
- journal article
- review article
- Published by Wiley in FEBS Letters
- Vol. 596 (5) , 534-556
Abstract
Systemic inflammatory disorders (SIDs) comprise a broad range of diseases characterized by dysregulated excessive innate immune responses. Severe forms of SIDs can lead to organ failure and death, and their increasing incidence represents a major issue for the healthcare system. Protease‐mediated ectodomain shedding of cytokines and their receptors represents a central mechanism in the regulation of inflammatory responses. The metalloprotease A disintegrin and metalloproteinase (ADAM) 17 is the best‐characterized ectodomain sheddase capable of releasing TNF‐α and soluble IL‐6 receptor, which are decisive factors of systemic inflammation. Recently, meprin metalloproteases were also identified as IL‐6 receptor sheddases and activators of the pro‐inflammatory cytokines IL‐1β and IL‐18. In different mouse models of SID, particularly those mimicking a sepsis‐like phenotype, ADAM17 and meprins have been found to promote disease progression. In this review, we summarize the role of ADAM10, ADAM17, and meprins in the onset and progression of sepsis and discuss their potential as therapeutic targets.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (125440785 SFB 877_A9)
- Exzellenzclusters Entzündungsforschung (8978316)
This publication has 224 references indexed in Scilit:
- The metalloproteases meprin α and meprin β: unique enzymes in inflammation, neurodegeneration, cancer and fibrosisBiochemical Journal, 2013
- Urine proteomics for discovery of improved diagnostic markers of Kawasaki diseaseEMBO Molecular Medicine, 2012
- The substrate degradome of meprin metalloproteases reveals an unexpected proteolytic link between meprin β and ADAM10Cellular and Molecular Life Sciences, 2012
- Early rise in circulating endothelial protein C receptor correlates with poor outcome in severe sepsisIntensive Care Medicine, 2011
- Engagement of CD44 by hyaluronan suppresses TLR4 signaling and the septic response to LPSMolecular Immunology, 2009
- MEP1A allele for meprin A metalloprotease is a susceptibility gene for inflammatory bowel diseaseMucosal Immunology, 2009
- The Compensatory Anti-inflammatory Response Syndrome (CARS) in Critically Ill PatientsClinics in Chest Medicine, 2008
- Metalloproteases regulate T‐cell proliferation and effector function via LAG‐3The EMBO Journal, 2007
- Biomarker and drug-target discovery using proteomics in a new rat model of sepsis-induced acute renal failureKidney International, 2006
- Acute-Phase Proteins and Other Systemic Responses to InflammationNew England Journal of Medicine, 1999